How to Get Addyi in South Carolina: Telehealth, Prescriptions, and Pharmacies

What Is Flibanserin and Why South Carolina Women Are Seeking It

Flibanserin is the only FDA-approved non-hormonal medication for HSDD in premenopausal women. It works centrally, reducing serotonin activity at 5-HT2A receptors while increasing dopamine and norepinephrine, a mechanism distinct from anything used in sexual dysfunction treatment before 2015 1. The FDA granted approval on August 18, 2015, after the agency reviewed three Phase 3 trials collectively showing statistically significant improvements in satisfying sexual events (SSEs) and sexual desire scores 2.

HSDD affects an estimated 8 to 10 percent of U.S. women, and many clinicians believe that number is under-reported because of persistent stigma around discussing low desire with a provider 3. South Carolina has seen growing telehealth adoption since the state's 2017 telehealth parity law, which means more SC women now have a practical path to evaluation and prescription without traveling to a specialist.

The BEGONIA trial (N=1,378, published J Sex Med 2014) found that flibanserin 100 mg nightly produced a mean increase of 0.5 SSEs per 28 days compared with placebo (1.0 vs. 0.5, P<0.001) alongside significant improvements on the Female Sexual Function Index desire subscale 4. Two additional key studies, DAISY and VIOLET, replicated those findings. Across all three trials, the most common adverse effects were dizziness (11.4%), somnolence (11.2%), and nausea (10.4%) 5.

The Regulatory Status of Addyi in South Carolina

South Carolina follows federal FDA regulations for Schedule-unscheduled prescription drugs like flibanserin. Addyi is not a controlled substance 6. The original Risk Evaluation and Mitigation Strategy (REMS) that restricted prescribing to certified providers was removed by the FDA in April 2019, opening the drug to any licensed prescriber 7.

That change matters for SC patients. Before 2019, finding a REMS-certified clinician in a rural South Carolina county could be difficult. Today, every MD, DO, NP, and PA licensed in South Carolina with prescribing authority may write a flibanserin prescription. The state's Nurse Practice Act (S.C. Code Ann. § 40-33-20) gives advanced practice registered nurses collaborative prescriptive authority, and physician assistants prescribe under SC Code § 40-47-935, meaning APRN and PA telehealth providers are fully eligible 8.

Telehealth prescribing in South Carolina is governed by S.C. Code Ann. § 40-47-37, which requires a valid patient-provider relationship but does not mandate an in-person encounter for establishing that relationship. A synchronous video visit satisfies this requirement for most prescribers, and some asynchronous platforms use secure questionnaires that meet the standard when paired with a provider review.

Step-by-Step: How to Get an Addyi Prescription in South Carolina

Getting Addyi in South Carolina follows a predictable sequence regardless of whether you choose telehealth or an in-office visit.

Step 1. Choose a prescribing pathway. Telehealth platforms that operate in South Carolina (including general women's health telehealth services and specialized sexual health practices) can evaluate and prescribe flibanserin entirely online. An in-person gynecologist, primary care physician, or psychiatrist is equally valid. Both pathways take roughly the same clinical time.

Step 2. Complete the clinical intake. The prescriber must confirm that your low desire is generalized (not situational), is causing personal distress, and is not better explained by a co-occurring condition such as major depression, genitopelvic pain disorder, or hypothyroidism 9. Validated screening tools used include the Female Sexual Distress Scale-Revised (FSDS-R) and the HSDD Screener for Women. A score of 11 or higher on the FSDS-R indicates clinically meaningful distress 10.

Step 3. Complete required labs. Liver function testing is mandatory because flibanserin is hepatically metabolized via CYP3A4, and hepatic impairment raises plasma levels to potentially unsafe concentrations 11. Required labs before initiation include ALT, AST, and total bilirubin. A urine or serum pregnancy test is standard practice because safety data in pregnancy are absent 12.

Step 4. Alcohol-risk counseling. Even without an active REMS, the FDA-approved labeling retains a boxed warning for the combination of flibanserin and alcohol, which may cause hypotension and syncope 13. Every prescribing clinician is expected to document this counseling before the first prescription.

Step 5. Prescription sent to pharmacy. The prescriber routes the Rx electronically to a retail, specialty, or compounding pharmacy licensed in South Carolina. Brand Addyi ships directly from Sprout Pharmaceuticals' specialty pharmacy partner network; compounded flibanserin ships from any SC-registered 503A compounding pharmacy.

Step 6. Titration and follow-up. The dose is fixed at 100 mg nightly. There is no titration. The FDA label recommends assessing response at 8 weeks; if no benefit is apparent, the drug should be discontinued 14.

Labs Required Before Flibanserin in South Carolina

Liver function testing is the single non-negotiable lab before prescribing flibanserin. Flibanserin is contraindicated in patients with any degree of hepatic impairment based on pharmacokinetic studies showing a 4.5-fold increase in AUC in subjects with mild impairment compared to healthy volunteers 15.

A standard pre-prescription lab panel for South Carolina providers typically includes:

• ALT and AST (alanine and aspartate aminotransferases)
• Total and direct bilirubin
• Urine or serum hCG (pregnancy screen)
• TSH if thyroid disease has not been excluded as a contributor to low desire 16

Many telehealth platforms offer a lab requisition at the time of intake, directing the patient to a nearby LabCorp or Quest location in South Carolina. Results typically return within 24 to 48 hours, and the provider clears the prescription once values confirm normal hepatic function.

Telehealth Providers Prescribing Addyi in South Carolina

South Carolina explicitly permits telehealth prescribing for non-controlled substances via synchronous video or, under certain conditions, asynchronous platforms 17. This matters because flibanserin is not a controlled substance and therefore faces none of the additional federal telemedicine restrictions imposed on scheduled drugs after the COVID-19 public health emergency.

A structured evaluation framework for SC telehealth Addyi visits includes four components: (1) validated desire and distress screening (FSDS-R, HSDD Screener), (2) exclusion of treatable contributing diagnoses via history and labs, (3) documented alcohol-risk counseling, and (4) review of the patient's current medication list for CYP3A4 inhibitors (fluconazole, ketoconazole, clarithromycin, and grapefruit products are contraindicated) 18.

The American College of Obstetricians and Gynecologists (ACOG) acknowledges flibanserin as an appropriate treatment for premenopausal women with HSDD, noting in their Committee Opinion No. 780: "Clinicians should be prepared to discuss FDA-approved pharmacologic options including flibanserin with patients who have HSDD and find their symptoms distressing" 19. Telehealth visits fully satisfy this clinical interaction standard when providers follow validated intake protocols.

Typical SC telehealth visit times for an Addyi evaluation run 20 to 30 minutes for a new patient. Follow-up visits at 8 weeks average 10 to 15 minutes.

Pharmacy Access: Where to Fill Addyi in South Carolina

Brand Addyi is available through retail pharmacies in South Carolina that stock or can order it. Because it has low dispensing volume relative to most primary care drugs, many pharmacies do not keep it on-shelf. Calling ahead or using the Sprout Pharmaceuticals pharmacy locator is advisable.

South Carolina has multiple 503A compounding pharmacies licensed by the SC Board of Pharmacy and in good standing with NABP e-Profile verification. A 503A pharmacy may compound flibanserin for individual patient prescriptions when a prescriber indicates a clinical need, such as a lower dose for a patient experiencing significant side effects at 100 mg, or a different dosage form 20. Compounded flibanserin is not bioequivalent-tested against brand Addyi; switching between brand and compounded formulations should be done under prescriber supervision.

Pricing without insurance:

• Brand Addyi 100 mg (30 tablets): approximately $400 to $800 per month depending on pharmacy and any manufacturer coupon
• Compounded flibanserin: pricing varies by pharmacy, typically $80 to $200 per month
• Sprout Pharmaceuticals offers a savings card at addyi.com that may reduce brand cost for commercially insured patients

South Carolina Medicaid (Healthy Connections) does not cover Addyi 21. Commercial plans vary. Prior authorization is common and typically requires documentation of an HSDD diagnosis, FSDS-R score, failure to respond to or contraindication to non-pharmacologic therapy, and a note from the prescribing clinician.

Prior Authorization Requirements in South Carolina

Commercial insurance prior authorization for flibanserin in South Carolina generally requires the following documentation:

• ICD-10 diagnosis code F52.0 (hypoactive sexual desire disorder) on the claim
• Confirmation of premenopausal status (FSH level or clinical documentation)
• FSDS-R score of 11 or higher, or equivalent validated measure
• Documentation that non-pharmacologic approaches (sex therapy, relationship counseling) were discussed or attempted 22
• Liver function results within normal limits
• Attestation of alcohol-risk counseling

The Endocrine Society's 2019 clinical practice guideline on female sexual dysfunction states: "We recommend that clinicians evaluate and treat contributing medical, psychological, and relationship factors before or alongside pharmacotherapy for HSDD" 23. Insurers often cite this guideline to require documentation of psychosocial evaluation in PA requests.

PA turnaround in South Carolina ranges from 3 to 15 business days depending on the payer. Appeals are available if the initial request is denied; the most successful appeals include the full FSDS-R scoring sheet and a letter of medical necessity from the prescriber.

Drug Interactions: What South Carolina Patients Must Know Before Starting

Flibanserin carries multiple clinically significant drug interactions that any prescriber must screen before writing the prescription 24.

Strong CYP3A4 inhibitors are contraindicated with flibanserin. This includes:

• Azole antifungals: fluconazole, itraconazole, ketoconazole, posaconazole
• Macrolide antibiotics: clarithromycin, telithromycin
• HIV protease inhibitors: ritonavir, indinavir, nelfinavir, saquinavir
• Grapefruit and grapefruit juice 25

Moderate CYP3A4 inhibitors (ciprofloxacin, fluoxetine, oral contraceptives containing ethinyl estradiol) increase flibanserin exposure and require caution; the prescriber should weigh risk-benefit and consider dose timing adjustments 26.

Alcohol consumed within hours of flibanserin produces additive CNS depression and hypotension. A crossover pharmacodynamic study (N=25) showed that combined ingestion of flibanserin 100 mg and alcohol 0.4 g/kg to 0.8 g/kg produced orthostatic hypotension in 4 of 23 evaluable subjects (17%) compared with zero in the flibanserin-alone arm 27.

CNS depressants including benzodiazepines, sedating antihistamines, and opioids may increase sedation risk. Patients on these agents should discuss timing strategies (for example, taking flibanserin at least 2 hours after any evening benzodiazepine dose) with their prescriber.

Transferring an Existing Addyi Prescription to South Carolina

South Carolina pharmacies accept valid out-of-state prescriptions for non-controlled substances. If you are relocating to South Carolina or have an existing Addyi prescription from another state, the transfer process is straightforward:

1. Contact a SC-licensed pharmacy and provide the prescription number and originating pharmacy contact information.
2. The new pharmacy verifies the Rx directly with the originating pharmacy via phone or electronic transfer.
3. Flibanserin is not a controlled substance, so DEA transfer restrictions do not apply 28.
4. If the original prescription has no remaining refills, a new SC-based prescriber can issue a new prescription after a brief telehealth or in-person evaluation, typically 10 to 15 minutes if records from the prior prescriber are available.

Telehealth platforms operating across state lines in South Carolina can also accept transferred care. Provide prior visit notes, lab results, and the previous prescriber's contact information to minimize intake time.

What to Expect in the First 8 Weeks on Flibanserin

The bedtime dosing schedule exists for a specific reason. CNS side effects, dizziness, somnolence, and fatigue, are highest in the first 1 to 2 hours after ingestion 29. Taking the pill at bedtime means peak plasma concentration occurs during sleep for most patients, reducing daytime impairment.

Onset of therapeutic effect is gradual. Clinical trial data show no statistically significant separation from placebo before week 4. The BEGONIA trial found maximum benefit at week 24, suggesting that patients who abandon treatment at week 3 or 4 because of perceived lack of effect may be discontinuing prematurely 30.

Tracking progress before the 8-week follow-up visit helps the provider make an objective discontinuation decision. Patients can use a simple SSE diary (a daily log of sexual events rated as satisfying by the patient) and re-administer the FSDS-R at week 8 to compare against baseline 31.

Side-effect management tips from the FDA label 32:

• Dizziness: ensure pill is taken lying down or immediately before bed; avoid standing quickly during the night
• Nausea: a light snack before bedtime may reduce gastric irritation
• Somnolence: typically self-resolves within 2 to 4 weeks as tolerance to CNS effects develops

Discontinuation does not require tapering. If you stop flibanserin, sexual desire returns to baseline within days because the drug has a half-life of approximately 11 hours 33.

Cost-Reduction Strategies for South Carolina Patients

Brand Addyi's list price puts it out of reach for many uninsured SC patients. Three concrete options reduce out-of-pocket cost:

Sprout Savings Card. Commercially insured patients may pay as little as $99 per month with the manufacturer's savings card. The card is available at addyi.com and requires no income documentation.

Compounded Flibanserin via 503A. SC-licensed 503A pharmacies can prepare flibanserin capsules at substantially lower cost, typically $80 to $200 for 30 doses. The prescriber must write a prescription specifying the compound; the pharmacy is responsible for sourcing pharmaceutical-grade API 34.

GoodRx and Pharmacy Discount Cards. GoodRx coupons for Addyi at major SC retail chains (CVS, Walgreens, Publix, Kroger) can reduce cost by 15 to 40 percent compared with list price. Prices vary by zip code; checking the GoodRx website for your specific SC city before choosing a pharmacy is advisable.

South Carolina's Healthy Connections Medicaid program does not cover Addyi, and no state pharmaceutical assistance program currently lists flibanserin as a covered drug 35. Patients dependent on public coverage may find compounded formulations the only financially practical option.